Trial · NCT06660004
Creatine HCl and Creatine Ethyl Ester Supplementation in Perimenopausal and Menopausal Women
NCT06660004, Not applicable, Completed, University of Novi Sad, Faculty of Sport and Physical Education
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Creatine HCl and Creatine Ethyl Ester Supplementation in Perimenopausal and Menopausal Women. Trials, record NCT06660004. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06660004
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Creatine HCl and Creatine Ethyl Ester Supplementation in Perimenopausal and Menopausal Women
- NCT number
- NCT06660004
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 36 participants, actual
- Lead sponsor
- University of Novi Sad, Faculty of Sport and Physical Education
- Conditions
- Menopausal, Perimenopause
- Interventions
- Dietary Supplement: Experimental 1 Creatine HCl, Dietary Supplement: Experimental 2 Creatine HCl, Dietary Supplement: Experimental 3 Creatine Ethyl ester, Dietary Supplement: Experimental 4 Placebo
- First posted
- 2024-10-26
- Last updated
- 2025-12-16
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Fatigue | Change from baseline fatigue at 8 weeks | Level of fatigue as assessed by the Multidimensional Fatigue Inventory (MFI) |
| Secondary | Time to exhaustion | Change from baseline time to exhaustion at 8 weeks | Running time to exhaustion during incrementaltestontreadmill |
| Secondary | Brain creatine | Change from baseline brain creatine concentrations at 8 weeks | Magnetic resonance spectra for brain creatine concentrations |
| Secondary | Cognitive interference | Change from baseline fatigue at 8 weeks | Ability to inhibit cognitive interference as assessed by the The Stroop Color and Word Test |
| Secondary | Amyloid b | Change from baseline time to exhaustion at 8 weeks | Serum levels of amyloid b |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06660004
GET https://conductscience.org/api/trials/v1/NCT06660004/registered